Recently, the German Chemical Industry Association (VCI) stated that despite the "better than expected" performance of Germany's chemical and pharmaceutical industries at the beginning of the year, the organization has maintained its 2025 forecast unchanged. VCI said, "Chemical production may stagnate this year, and industry sales may decline slightly. If the tariff conflict does not escalate further, the prospects for the chemical industry could improve as early as this year."
VCI noted that the chemical industry across countries saw a significant increase in production and sales in the first quarter of 2025, making up for the economic recession in previous months. However, VCI believes many companies fear setbacks in the coming months. The organization reported, "The U.S. government's unstable tariff policies are reducing export opportunities for the chemical industry and its customers. Additionally, Chinese goods intended for export to the U.S. may increasingly shift to Europe, increasing import pressure in Europe."
In Germany, chemical production (excluding pharmaceuticals) fell 0.9% year-on-year in the first quarter but rose 4.7% quarter-on-quarter. Chemical and pharmaceutical production increased 1.2% year-on-year and 6.7% quarter-on-quarter. The producer price index rose 1.1% year-on-year and 0.6% quarter-on-quarter. VCI stated that Germany's chemical capacity utilization was 78.2%, compared with 74.7% in the fourth quarter of 2024, though still below the profitability threshold. The first-quarter improvement affected nearly all sectors and was driven by strong operations in both Germany and abroad.
Total sales of Germany's chemical and pharmaceutical industries rose 4.4% quarter-on-quarter and 1.8% year-on-year to €54.8 billion. Domestic sales in Germany rose 4.3% quarter-on-quarter and 2.2% year-on-year, while sales in other countries outside Germany rose 4.5% quarter-on-quarter and 1.8% year-on-year.